BRAINSTORM CELL THERAPEUTICS INC. Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31)
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) of $0 for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Notes
us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments · last filed 2013-05-09
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for fiscal 2012 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for fiscal 2011 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for fiscal 2010 was $0.00.
| Period end | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 3 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 6 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 9 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 12 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 129 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 132 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 135 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 138 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 141 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 144 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 147 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 150 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-05-09 | $0.00 derived: sum of 3 quarters · filed 2013-05-09 | $0.00 derived: sum of 4 quarters · filed 2013-05-09 | $795.00K 10-Q · filed 2013-05-09 | |||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $0.00 derived: sum of 2 quarters · filed 2013-03-14 | $0.00 derived: sum of 3 quarters · filed 2013-03-14 | $0.00 10-K · filed 2013-03-14 | $795.00K 10-K · filed 2013-03-14 | |||||||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 4 quarters · filed 2013-05-09 | $795.00K 10-Q · filed 2012-11-13 | |||||||
| 2012-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-29 | $0.00 10-Q/A · filed 2012-08-29 | $0.00 derived: sum of 3 quarters · filed 2013-05-09 | $0.00 derived: sum of 4 quarters · filed 2013-05-09 | $795.00K 10-Q/A · filed 2012-08-29 | |||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-05-09 | $0.00 derived: sum of 3 quarters · filed 2013-05-09 | $0.00 derived: sum of 4 quarters · filed 2013-05-09 | $795.00K 10-Q · filed 2012-05-11 | |||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $0.00 derived: sum of 2 quarters · filed 2013-03-14 | $0.00 derived: sum of 3 quarters · filed 2013-03-14 | $0.00 10-K · filed 2013-03-14 | $795.00K 10-K · filed 2012-03-15 | |||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $0.00 10-Q · filed 2012-11-13 | $0.00 derived: sum of 4 quarters · filed 2012-11-13 | $795.00K 10-Q · filed 2011-11-14 | |||||||
| 2011-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-29 | $0.00 10-Q/A · filed 2012-08-29 | $0.00 derived: sum of 3 quarters · filed 2012-08-29 | $0.00 derived: sum of 4 quarters · filed 2012-08-29 | $795.00K 10-Q/A · filed 2011-09-07 | |||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-11 | $0.00 derived: sum of 2 quarters · filed 2012-05-11 | $0.00 derived: sum of 3 quarters · filed 2012-05-11 | |||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $0.00 derived: sum of 2 quarters · filed 2012-03-15 | $0.00 10-K · filed 2012-03-15 | |||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||||||||||
| 2010-06-30 | $0.00 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |